T42.72 Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm

Name of the Condition

Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm
ICD-10 Code: T42.72

Summary

This code describes intentional self-harm resulting from the ingestion of unspecified antiepileptic or sedative-hypnotic drugs. It applies to clinical scenarios where the patient intentionally exposes themselves to these medications with the intent to cause harm, and the specific drug within the class is not identified. The classification is based on the intentional nature of the act and the clinical context of self-harm.

Causes

Intentional self-harm by these drugs typically involves deliberate overdose, often as a means of self-inflicted injury or suicide attempt. It may result from the use of available medications in the home, including those prescribed for epilepsy, sleep disorders, or other conditions. The act is characterized by a conscious decision to ingest the drug(s) with harmful intent.

Risk Factors

• Access to antiepileptic or sedative-hypnotic medications in the home.
• History of mental health conditions, such as depression or suicidal ideation.
• Prior self-harm or suicide attempts.
• Social isolation or lack of support systems.
• Substance use disorders or comorbid psychiatric conditions.

Symptoms

• Severe drowsiness or coma.
• Respiratory depression or arrest.
• Confusion, disorientation, or altered mental status.
• Seizures or abnormal motor activity.
• Nausea, vomiting, or abdominal pain.
• Hypotension or cardiovascular instability.

Diagnosis

Diagnosis requires a thorough patient history to confirm intentional self-harm and identify the drug class involved. Clinical assessment focuses on the nature of the exposure, timing, and intent. Laboratory tests, such as toxicology screens, may be used to detect drug levels, though the specific agent may remain unspecified. Vital sign monitoring and neurological evaluation are critical to assess severity.

Treatment Options

• Immediate stabilization of airway, breathing, and circulation (ABCs).
• Administration of activated charcoal to limit drug absorption if within a safe timeframe.
• Supportive care, including intravenous fluids, respiratory support, or medications to manage seizures or hypotension.
• Psychiatric evaluation and intervention to address underlying mental health concerns.
• Consideration of antidotes or specific treatments based on clinical presentation.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying health status. Early intervention improves outcomes, but severe cases may result in long-term complications or death. Follow-up includes monitoring for residual effects, psychiatric care, and safety planning to prevent recurrence.

Complications

• Respiratory failure requiring mechanical ventilation.
• Seizures or neurological damage.
• Cardiovascular instability or cardiac arrest.
• Acute kidney injury or hepatic toxicity.
• Long-term cognitive or psychiatric sequelae.

Lifestyle & Prevention

• Secure storage of medications to limit access.
• Education on safe medication use and disposal.
• Regular mental health screening and support for at-risk individuals.
• Involvement of family or caregivers in medication management.
• Access to crisis intervention resources and counseling.

When to Seek Professional Help

Seek immediate medical attention if self-harm is suspected or if symptoms of poisoning (e.g., drowsiness, confusion, respiratory distress) occur after medication ingestion. Prompt evaluation is critical to prevent life-threatening complications.

Tips for Medical Coders

Use T42.72 when documenting intentional self-harm involving unspecified antiepileptic or sedative-hypnotic drugs. Ensure clinical documentation clearly supports the intentional nature of the act and the drug class. Include details about the patient’s intent, timing, and clinical presentation to justify code assignment. Verify that the code aligns with the specific encounter type (e.g., initial, subsequent) as required.